Perspective Therapeutics, Inc. — Director's Dealing 2012

May 10, 2012

SEC Form 4/A — Form 4/A

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2011-11-17

Reporting Person: Babcock Dwight William (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-17	Common Stock	P	2500	$0.77	Acquired	163773	Direct
2011-11-18	Common Stock	P	500	$0.83	Acquired	164273	Direct
2011-11-21	Common Stock	P	400	$0.84	Acquired	164673	Direct
2011-11-21	Common Stock	P	1100	$0.8499	Acquired	165773	Direct

Footnotes

F1: This amendment is being filed to correct the total securities benefically owned in Column 5 from the original Form 4 filing on November 22, 2011. No changes have been made to the reported purchases. This correction was previously filed via Form 4 on April 23, 2012, but the filing was inadvertently filed as a new Form 4 and not as an amendment to the Form 4 filing filed on November 22, 2011.